JPMorgan, Pfizer, Exxon: Dow Midday Movers

NEW YORK ( TheStreet) -- U.S. stocks were rising midday Monday after Federal Reserve Chairman Ben Bernanke's remarks on the long-term unemployment situation pointed to the possible need for more stimulus funding.

The Dow Jones Industrial Average rose 133.58 points to 13,214.31. Leading the Dow higher were JPMorgan Chase ( JPM), Pfizer ( PFE) and Exxon Mobil ( XOM).

Shares of JPMorgan rose 1.82% to $45.98. The bank is on track to top the merger advisory, equity and debt underwriting rankings.

TheStreet Ratings gives JPMorgan a B+ grade with a buy rating and a $51.57 price target.

Pfizer shares rose 1.83% to $22.22. The drug company's oncology division will present information about some of its clinical and preclinical studies at the annual American Association for Cancer Research meeting at the end of March.

Pfizer gets an A- grade from TheStreet Ratings with a buy rating and a $28.52 price target.

Shares of Exxon rose 1.8% to $87.09. TheStreet Ratings gives Exxon Mobil a B+ grade with a buy rating and a $101.73 price target.

The Dow stocks posting declines midday Monday were Procter & Gamble ( PG) and Verizon ( VZ). Both were down less than 1%.

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here: Alexandra Zendrian

>To submit a news tip, send an email to: tips@thestreet.com.

>To follow the writer on Twitter, go to Alexandra Zendrian.

More from Investing

5 Things Investors Should Read Before Coming Earnings Season Blowout

5 Things Investors Should Read Before Coming Earnings Season Blowout

4 of the Most Highly-Anticipated Tech IPOs in the Pipeline

4 of the Most Highly-Anticipated Tech IPOs in the Pipeline

Video: Don't Underestimate China's Strength in a Trade War

Video: Don't Underestimate China's Strength in a Trade War

Tesla: What Are Wall Street's Best Analysts Saying Now?

Tesla: What Are Wall Street's Best Analysts Saying Now?

Master Limited Partnerships: A Badly Missed Investment Opportunity?

Master Limited Partnerships: A Badly Missed Investment Opportunity?